These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 6944552

  • 1. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct; 67(4):863-9. PubMed ID: 6944553
    [Abstract] [Full Text] [Related]

  • 3. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH, van de Plas MM, Steerenberg PA, Kruizinga W, Ruitenberg EJ.
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [Abstract] [Full Text] [Related]

  • 4. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ, Kataoka T, Hanna MG.
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [Abstract] [Full Text] [Related]

  • 5. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
    Key ME, Brandhorst JS, Hanna MG.
    J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of BCG induced regression of line 10 hepatocarcinoma in the guinea pig.
    Steerenberg PA, De Jong WH, Ruitenberg EJ.
    In Vivo; 1991 Jun; 5(6):655-61. PubMed ID: 1810452
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG, Peters LC.
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [Abstract] [Full Text] [Related]

  • 8. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery.
    Hanna MG, Peters LC.
    Cancer; 1978 Dec; 42(6):2613-25. PubMed ID: 728864
    [Abstract] [Full Text] [Related]

  • 9. Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells.
    Nagai A, Zbar B, Terata N, Hovis J.
    Cancer Res; 1983 Dec; 43(12 Pt 1):5783-8. PubMed ID: 6315216
    [Abstract] [Full Text] [Related]

  • 10. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.
    Brunda MJ, Mathews HL, Ferguson HR, McClatchy JK, Minden P.
    Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of immunologic eradication of a syngeneic guinea pig tumor. I. Quantitative analysis of adoptive immunity.
    Shu S, Hunter JT, Rapp HJ, Fonseca LS.
    J Natl Cancer Inst; 1982 Apr; 68(4):673-80. PubMed ID: 6951081
    [Abstract] [Full Text] [Related]

  • 12. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P, Mathews HL.
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [Abstract] [Full Text] [Related]

  • 13. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 14. New monoclonal antibodies specific for the guinea pig line 10 hepatocarcinoma.
    Kataoka T, Chiba J, Ohnuki T, Nemoto K, Tokunaga T.
    Jpn J Cancer Res; 1987 Sep; 78(9):960-7. PubMed ID: 3117752
    [Abstract] [Full Text] [Related]

  • 15. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.
    Dvorak HF, Dvorak AM, Manseau EJ, Wiberg L, Churchill WH.
    J Natl Cancer Inst; 1979 Jun; 62(6):1459-72. PubMed ID: 286118
    [Abstract] [Full Text] [Related]

  • 16. Active specific immunotherapy of residual micrometastasis: the acute and chronic inflammatory response in induction of tumor immunity by BCG-tumor cell immunization.
    Hanna MG, Bucana C.
    J Reticuloendothel Soc; 1979 Oct; 26(4):439-51. PubMed ID: 513055
    [No Abstract] [Full Text] [Related]

  • 17. Immunological effects of BCG as an adjuvant in autologous tumor vaccines.
    Li Q, Normolle DP, Sayre DM, Zeng X, Sun R, Jiang G, Redman BD, Chang AE.
    Clin Immunol; 2000 Jan; 94(1):64-72. PubMed ID: 10607491
    [Abstract] [Full Text] [Related]

  • 18. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E, Ashley MP, Zbar B, Sugimoto T, Rapp HJ.
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.
    Ashley MP, Zbar B, Hunter JT, Rapp HJ, Sugimoto T.
    Cancer Res; 1980 Nov; 40(11):4197-203. PubMed ID: 7471060
    [Abstract] [Full Text] [Related]

  • 20. Localization of 111In- and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumors.
    Bernhard MI, Hwang KM, Foon KA, Keenan AM, Kessler RM, Frincke JM, Tallam DJ, Hanna MG, Peters L, Oldham RK.
    Cancer Res; 1983 Sep; 43(9):4429-33. PubMed ID: 6871875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.